Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (GB:0R2B)
LSE:0R2B
Holding GB:0R2B?
Track your performance easily
0R2B Stock Chart & Stats
Day’s Range― - ―
52-Week Range$222.79 - $283.88
Previous CloseN/A
Volume1.24K
Average Volume (3M)6.88K
Market Cap
$169.79B
Enterprise Value$217.11B
Total Cash (Recent Filing)$963.70M
Total Debt (Recent Filing)$9.67B
Price to Earnings (P/E)45.0
Beta1.00
Next Earnings
Jan 29, 2025EPS Estimate
2.15Last Dividend Ex-Date
Dec 27, 2024Dividend Yield0.46%
Share Statistics
EPS (TTM)5.24
Shares Outstanding722,275,150
10 Day Avg. Volume1,374
30 Day Avg. Volume6,879
Standard Deviation0.07
R-Squared0.02
Alpha0.00942
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.30
Price to Cash Flow (P/CF)28.60
P/FCF Ratio33.60
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue10.84
Enterprise Value/Gross Profit15.47
Enterprise Value/Ebitda34.28
Forecast
1Y Price Target
$283.12Price Target Upside20.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Danaher News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceStronger revenues and better operating margins resulted in adjusted EPS beating consensus estimates.
Market Position And GrowthDanaher used the investor day to showcase the DBS-driven commercial and innovation execution that is driving improved core growth and material margin expansion across the portfolio, both of which are outpacing peers.
Partnership And InnovationAn expanded partnership with Element Biosciences for exome sequencing protocols could enhance workflow efficiency and support various research applications.
Bears Say
China Market ChallengesChina's market remains weak with no expected near-term improvement, affecting instrumentation demand.
Guidance And Market ReactionThe stock declined due to a cautious 4Q guide that was below consensus and conservative management guidance for 2025.
Revenue Growth ConcernsConcerns exist on the pace of revenue growth improvement and valuation, with shares trading at a 25% premium to peers on an EPS basis.
---
Options Prices
Currently, No data available
---
Ownership Overview
4.05% Insiders
26.77% Mutual Funds
0.39% Other Institutional Investors
51.06% Public Companies and Individual Investors
0R2B FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest share price was $222.79 and its highest was $283.88 in the past 12 months.
What is Danaher Corp.’s market cap?
Danaher Corp.’s market cap is $169.79B.
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Jan 29, 2025 which is in 14 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Oct 22, 2024. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.569 by $0.141.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.46%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is 2.15.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 722,275,150 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $1.71 in its last earnings report, beating expectations of $1.569. Following the earnings report the stock price went down -3.63%.
Which hedge fund is a major shareholder of Danaher Corp.?
Currently, no hedge funds are holding shares in GB:0R2B
---
Danaher Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$283.12 (20.43% Upside)
$283.12 (20.43% Upside)
Blogger Sentiment
Bullish
GB:0R2B Sentiment 87%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $8.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.95%
12-Months-Change
Fundamentals
Return on Equity
7.59%
Trailing 12-Months
Asset Growth
-8.11%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
0R2B Company Deck
---
0R2B Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment with strong performance in the bioprocessing and diagnostics segments, particularly Cepheid, contrasted by challenges in China and the Life Sciences segment. Despite some positive indicators, such as sequential order growth in bioprocessing, the overall performance was tempered by declines in certain high-growth markets and continued caution among smaller customers.Read More>---
0R2B Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
0R2B Stock 12 Month Forecast
Average Price Target
$283.12
▲(20.43% Upside)
Technical Analysis
Danaher
―
Thermo Fisher
―
Agilent
―
Mettler-Toledo
―
Bio-Rad Laboratories
―
Stryker
―
Resmed
―
Best Analysts Covering 0R2B
1 Year
1 Year Success Rate
11/13 ratings generated profit
1 Year Average Return
+25.53%
upgraded a buy rating 2 months ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +25.53% per trade.
---